CiGuPhar
ActiveSummary
The computed 12-month bankruptcy probability of CiGuPhar is 3.8% (moderate). The 2025 annual accounts show equity of €41,683 and a net result of €5,741. Equity is shrinking by about 31% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2027. Its solvency ranks better than 29% of 13,618 sector peers (NACE 46, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
07-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
06-01
Gazette deed
Resignation: MEDICAZU CONSULTING & CONCEPT (manager)Appointment: COSMEX (director) · Permanent representative: Favoreel Sebastiaan · Amendment of the articles14 facts ▸
Gazette deed
Resignation: MEDICAZU CONSULTING & CONCEPT (manager)
Appointment: COSMEX (director) · Permanent representative: Favoreel Sebastiaan · Amendment of the articles14 facts ▸
- General meeting, “assemblée générale extraordinaire des actionnaires” (deed in Dutch)
- Amendment of the articles (3 times)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in Dutch)
- Reserve release, “compte de capitaux propres statutairement indisponible créé en application de l'article 39, §2, deuxième alinéa de la loi du 23 mars introduisant le Code des so…” (deed in Dutch)
- Capital
- Director resignation, MEDICAZU CONSULTING & CONCEPT (manager)
- Director discharge, MEDICAZU CONSULTING & CONCEPT
- Board rule, 1
- Director appointment, COSMEX (director (not named in the articles))
- Other provision, “absence d'interdiction pénale ou civile d'exercer une fonction administrative” (deed in Dutch)
- Other provision, 14-08-2025
- Permanent representative, Favoreel Sebastiaan
- +2 further facts in this act
2025
31-12
Financial
Weakest financial yearnet €5,741 ▼81.4%
Net result drops to €5,741, the lowest in the series.
25-11
Gazette deed
Resignation: MEDICAZU CONSULTING & CONCEPT (manager)Permanent representative: Favoreel Sebastiaan · Appointment: COSMEX (director) · Registered-office move14 facts ▸
Gazette deed
Resignation: MEDICAZU CONSULTING & CONCEPT (manager)
Permanent representative: Favoreel Sebastiaan · Appointment: COSMEX (director) · Registered-office move14 facts ▸
- General meeting, 03-09-2025
- Registered-office move, 1480 Tubize,Rue François Englert 10
- Amendment of the articles (3 times)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in Dutch)
- Reserve release, “suppression, fonds disponibles pour distribution” (deed in Dutch)
- Capital
- Director resignation, MEDICAZU CONSULTING & CONCEPT (manager)
- Director discharge, MEDICAZU CONSULTING & CONCEPT
- Permanent representative, Favoreel Sebastiaan (2 times)
- Board rule, 1
- Director appointment, COSMEX (director (not named in the articles))
- Other provision, “absence d'interdiction pénale ou civile d'exercer une fonction administrative” (deed in Dutch)
- +2 further facts in this act
10-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
26-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 26 days late
2023
31-12
Financial
Equity above €100,000equity €111,276 ▲28.5%
A profit in every financial year since 2022 builds equity to €111,276.
30-06
NBB filing
Annual accounts filed
financial year 2022 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
2 of 3 deeds read
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 2 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.